Main public logs

Nav

Combined display of all available logs of Pharmacopedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

01:53, 22 May 2026 MDElliottMD talk contribs created page Stephen Szára (Create stub: Stephen Szára (backs internal-linking redlinks; amended linking rule))
00:38, 22 May 2026 MDElliottMD talk contribs created page Category:Non-psychotropic medicines (Category taxonomy ship: create Category:Non-psychotropic medicines)
00:37, 22 May 2026 MDElliottMD talk contribs created page Category:Gnosis (Category taxonomy ship: create Category:Gnosis)
00:37, 22 May 2026 MDElliottMD talk contribs created page Category:Dynamis (Category taxonomy ship: create Category:Dynamis)
00:37, 22 May 2026 MDElliottMD talk contribs created page Category:Poeia (Category taxonomy ship: create Category:Poeia)
00:37, 22 May 2026 MDElliottMD talk contribs created page Category:Plants (Category taxonomy ship: create Category:Plants)
00:35, 22 May 2026 MDElliottMD talk contribs created page Category:Empathogens (Category taxonomy ship: create Category:Empathogens (renamed from Category:Empathogens / Entactogens))
00:35, 22 May 2026 MDElliottMD talk contribs created page Category:Sedative-hypnotics (Category taxonomy ship: create Category:Sedative-hypnotics (renamed from Category:Sedative-Hypnotics))
00:35, 22 May 2026 MDElliottMD talk contribs created page Category:Research chemicals (Category taxonomy ship: create Category:Research chemicals (renamed from Category:Research Materials))
00:35, 22 May 2026 MDElliottMD talk contribs created page Category:Nootropics/Cognitive enhancers (Category taxonomy ship: create Category:Nootropics/Cognitive enhancers (renamed from Category:Nootropics))
00:34, 22 May 2026 MDElliottMD talk contribs created page Category:Anti-addiction agents (Category taxonomy ship: create Category:Anti-addiction agents (renamed from Category:Addiction Medicine))
00:34, 22 May 2026 MDElliottMD talk contribs created page Category:Antimigraine agents (Category taxonomy ship: create Category:Antimigraine agents (renamed from Category:Migraine Medicines))
00:34, 22 May 2026 MDElliottMD talk contribs created page Category:Antiparkinsonism agents (Category taxonomy ship: create Category:Antiparkinsonism agents (renamed from Category:Antiparkinsonian Medicines))
00:34, 22 May 2026 MDElliottMD talk contribs created page Category:Antiepileptics (Category taxonomy ship: create Category:Antiepileptics (renamed from Category:Anticonvulsants))
00:18, 22 May 2026 MDElliottMD talk contribs created page Serotonin syndrome (Create stub: Serotonin syndrome (backs redlinks; Boyer 2005 NEJM cited))
00:18, 22 May 2026 MDElliottMD talk contribs created page Drug Enforcement Administration (Create stub: Drug Enforcement Administration (backs redlinks))
00:18, 22 May 2026 MDElliottMD talk contribs created page Alexander Shulgin (Create stub: Alexander Shulgin (backs redlinks per amended internal-linking rule))
18:28, 21 May 2026 MDElliottMD talk contribs created page Category:Alpha-2 Adrenergic Agonists (Tier 2 taxonomy consolidation: create canonical mechanism category Alpha-2 Adrenergic Agonists)
03:34, 21 May 2026 MDElliottMD talk contribs created page Template:ShulginsCorner (Create Template:ShulginsCorner: Pharma-axis sibling of PendellsCorner for verbatim PiHKAL/TiHKAL passages)
18:55, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP3A4 normal metabolizer (Sandbox-save CYP3A4 phenotype page per parser-claude 2026-05-20 source check: the DPWG cyp3a4_pm/cyp3a4_im interaction edges are valid data. DPWG runs a CYP3A4*22-based metabolizer-phenotype framework (PM/IM/NM) that CPIC does not endorse; the page states that distinction plainly. Cited: Wang 2011 PMID 20386561 (CYP3A4*22 functional), DPWG guideline PharmGKB PA166265421. Definitional satellite of Enzyme:CYP3A4. Final home Phenotype:CYP3A4 <level> metabolizer once namespace registered.)
18:55, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP3A4 intermediate metabolizer (Sandbox-save CYP3A4 phenotype page per parser-claude 2026-05-20 source check: the DPWG cyp3a4_pm/cyp3a4_im interaction edges are valid data. DPWG runs a CYP3A4*22-based metabolizer-phenotype framework (PM/IM/NM) that CPIC does not endorse; the page states that distinction plainly. Cited: Wang 2011 PMID 20386561 (CYP3A4*22 functional), DPWG guideline PharmGKB PA166265421. Definitional satellite of Enzyme:CYP3A4. Final home Phenotype:CYP3A4 <level> metabolizer once namespace registered.)
18:55, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP3A4 poor metabolizer (Sandbox-save CYP3A4 phenotype page per parser-claude 2026-05-20 source check: the DPWG cyp3a4_pm/cyp3a4_im interaction edges are valid data. DPWG runs a CYP3A4*22-based metabolizer-phenotype framework (PM/IM/NM) that CPIC does not endorse; the page states that distinction plainly. Cited: Wang 2011 PMID 20386561 (CYP3A4*22 functional), DPWG guideline PharmGKB PA166265421. Definitional satellite of Enzyme:CYP3A4. Final home Phenotype:CYP3A4 <level> metabolizer once namespace registered.)
06:33, 20 May 2026 User account Noob talk contribs was created Tags: Mobile edit Mobile web edit
03:40, 20 May 2026 MDElliottMD talk contribs created page ASRS-v1.1 (Redirect to Adult ADHD Self-Report Scale) Tag: New redirect
03:40, 20 May 2026 MDElliottMD talk contribs created page ASRS (Redirect to Adult ADHD Self-Report Scale) Tag: New redirect
03:26, 20 May 2026 MDElliottMD talk contribs created page Adult ADHD Self-Report Scale (Create encyclopedic page for the ASRS-v1.1 (Adult ADHD Self-Report Scale): development under the WHO (Kessler, Harvard; Adler, NYU), structure (18-item checklist + 6-item Screener), threshold scoring, validation, the DSM-5 update, wiki use as the validated companion to AMAAS, and the NYU/Harvard licensing + mandatory attribution notice. Citations Kessler 2005 PMID 15841682, Kessler 2007 PMID 17623385, Ustun 2017 PMID 28384801, all NCBI-eutils-verified. Describes the instrument; reproduces no...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Category:Pharmacogenomic phenotypes (Create Category:Pharmacogenomic phenotypes per the canonical category-page spec: descriptive history-first lead (the debrisoquine polymorphism, Smith at St Mary's London 1977, Mahgoub 1977 PMID 71400, origin of the poor/extensive metabolizer vocabulary; Weinshilboum 1980 TPMT PMID 7191632; the genotype-to-phenotype harmonisation Caudle 2020 PMID 31647186). Phenotypes-indexed list grouped by gene (26 pages). Notes on scope, About-these-pages, references. Carries Category:Pharmacogenomics paren...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype NUDT15 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype NUDT15 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype NUDT15 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype TPMT normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype TPMT intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype TPMT poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype UGT1A1 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype UGT1A1 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype UGT1A1 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 ultrarapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 rapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2B6 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C9 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C9 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C9 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 ultrarapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 rapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 normal metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 intermediate metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2C19 poor metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)
00:32, 20 May 2026 MDElliottMD talk contribs created page Pharmacopedia:Pharmacogenomics sandbox/Phenotype CYP2D6 ultrarapid metabolizer (Sandbox-save pharmacogenomic phenotype page (batch of 25 per Mark 2026-05-19, completing the metabolizer-phenotype set across the 7 enzymes with CPIC phenotype schemes). Definitional satellite of the parent enzyme page: lead defines the phenotype, sections cover genotype basis, population frequency, clinical consequences medicine-by-medicine, and phenocopying where it applies. CPIC/DPWG dosing guidance cited; all PMIDs NCBI-eutils-verified. Final home Phenotype:<NAME> once the namespace is re...)